Clinical Trials Logo

Clinical Trial Summary

Dengue is an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information.


Clinical Trial Description

French Guiana is a 250,000 inhabitant's French overseas department located in South America, the epidemiology of arboviruses has recently evolved and marked by important outbreaks.

Dengue remains an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03210363
Study type Interventional
Source Institut Pasteur
Contact
Status Completed
Phase N/A
Start date June 9, 2017
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT01868399 - Pilot Survey of Dengue Fever in Solomon Islands N/A
Recruiting NCT05452447 - Spatial Repellents for Aedes-borne Virus Control in Sri Lanka N/A
Recruiting NCT03552094 - World Mosquito Program Noumea - Human Sample Component
Completed NCT03553277 - Spatial Repellents for Arbovirus Control N/A
Completed NCT00116766 - Field Evaluation of Plant-based Mosquito Control Phase 2
Recruiting NCT04615364 - Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
Recruiting NCT04954352 - Human Epidemiology of Newly Identified Arboviruses
Completed NCT06268691 - Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating N/A
Recruiting NCT04619823 - Virological and Immunological Determinants of Arbovirus Infection in New Caledonia N/A